Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) Debt to Equity (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Debt to Equity for 3 consecutive years, with $0.15 as the latest value for Q1 2026.

  • Quarterly Debt to Equity rose 186.5% to $0.15 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $0.15 through Jan 2026, up 186.5% year-over-year, with the annual reading at $0.2 for FY2025, 198.49% up from the prior year.
  • Debt to Equity for Q1 2026 was $0.15 at Kestra Medical Technologies, down from $0.26 in the prior quarter.
  • The five-year high for Debt to Equity was $0.26 in Q4 2025, with the low at -$0.2 in Q2 2024.
  • Average Debt to Equity over 3 years is $0.08, with a median of $0.17 recorded in 2025.
  • The sharpest move saw Debt to Equity soared 198.49% in 2025, then surged 186.5% in 2026.
  • Over 3 years, Debt to Equity stood at -$0.2 in 2024, then soared by 225.62% to $0.26 in 2025, then crashed by 42.5% to $0.15 in 2026.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.15, $0.26, and $0.23 for Q1 2026, Q4 2025, and Q3 2025 respectively.